Sports Betting Addiction Lawsuit Sports betting addiction lawsuits are being investigated for college students and young adults who developed gambling problems after using apps like FanDuel and DraftKings, alleging that the platforms failed to warn about the addictive nature of their features and marketing practices.
Nitrous Oxide Lawsuit Individuals who suffered harm, or families who lost a loved one after using nitrous oxide products may be eligible for financial compensation through a nitrous oxide lawsuit.
Hair Relaxer Lawsuit Regular exposure to chemicals in hair relaxer may cause uterine cancer, ovarian cancer and other injuries. Women diagnosed with cancer may be eligible for settlement benefits.
Depo-Provera Lawsuit Depo-Provera lawsuits are being investigated for women who developed meningioma brain tumors after receiving Depo-Provera birth control shots, claiming that Pfizer failed to adequately disclose side effects.
Ozempic Lawsuit Lawyers are pursuing Ozempic lawsuits, Wegovy lawsuits and Mounjaro lawsuits over gastroparesis or stomach paralysis, which can leave users with long-term gastrointestinal side effects
Suboxone Tooth Decay Lawsuit Lawsuits are being pursued by users of Suboxone who experienced tooth loss, broken teeth or required dental extractions. Settlement benefits may be available.
Change Healthcare Lawsuit Lawyers are reviewing Change Healthcare class action lawsuits for individuals who had their personal information stolen due to the data breach.
Bard PowerPort Lawsuit Serious and life-threatening injuries have been linked to problems with Bard PowerPort. Lawsuits are now being pursued by individuals who suffered injuries from the implantable port catheter fracturing or migrating.
AngioDynamics Port Catheter Lawsuit Serious and life-threatening injuries have been linked to problems with Bard PowerPort. Lawsuits are now being pursued by individuals who suffered injuries from the implantable port catheter fracturing or migrating.
Processed Food Lawsuit Lawsuits are being pursued against the food industry over their manufacturing and advertising of ultra-processed foods, which have caused a generation of children to face an increased risk of developing childhood diabetes and other chronic illnesses.
New Baby Formula Standards Require More Safety Testing June 10, 2014 Martha Garcia Add Your Comments The FDA announced the finalization this week of new rules designed to make baby formula safer, requiring that manufacturers demonstrate the formula supports a baby’s normal physical growth and that the formula is properly tested. The new FDA infant formula rules provide safety standards for manufacturers and encourage practices that may prevent harm for babies. Among the new rules are requirements that manufacturers conduct testing to ensure disease-causing bacteria, such as Salmonella and Cronobacter, are kept of out baby formula. BABY FORMULA NEC LAWSUITS Was your premature child fed Similac or Enfamil? Premature infants fed Similac or Enfamil cow’s milk formula face an increased risk of necrotizing enterocolitis (NEC) or wrongful death. Learn More SEE IF YOU QUALIFY FOR COMPENSATION BABY FORMULA NEC LAWSUITS Was your premature child fed Similac or Enfamil? Premature infants fed Similac or Enfamil cow’s milk formula face an increased risk of necrotizing enterocolitis (NEC) or wrongful death. Learn More SEE IF YOU QUALIFY FOR COMPENSATION Manufactures will also be required to demonstrate that the formula supports normal physical growth, and test for nutrient content in the final product stage, before the formula is allowed on the market, and again at the end of a product’s shelf life. “This rule will set in place federally enforceable requirements for the safety and quality of infant formula,” said Stephan Ostroff, FDA’s acting chief scientist, in the FDA news brief. The rules will only apply to infant formulas used by healthy babies without unusual medical or dietary problems. The FDA reported many infant formula manufacturers in the U.S. have already voluntarily applied many of the current good manufacturing practices and quality control procedures outlined in the final rule. The rules were initially published as interim rules on February 10. After receiving feedback during the open comment period, the FDA made adjustments before releasing the details of the final rules. Manufacturers will be required to comply by the new rules set forth by September 8, 2014. The FDA does not approve infant formula before it goes to market, however, all formulas marketed in the U.S. must meet federal nutrient requirements, which were not changed by the rule. The FDA does hold other regulatory authority over formula manufacturers to help ensure the formula manufactured is safe for consumption. Manufacturers are required to register with the FDA and provide the agency with notification before marketing a new formula. In addition, the FDA conducts a yearly inspection of facilities that manufacture infant formula. The FDA also collects and analyzes samples from the facilities to ensure product safety, and inspects new facilities. If the FDA deems an infant formula is a risk to infants, the manufacturer is required to issue a product recall. Experts recommend that infants be breastfed to receive optimal nutrition, yet many infants still rely on formula for a some or all of their nutrition. One million infants are fed formula at birth in the U.S., by three months of age more than 2.7 million babies are fed formula. Infant formulas are sold in powder, liquid concentrate and ready to feed liquid forms. The FDA sets specifications for nutrient content for infant formula, yet many manufacturers set levels above what the FDA dictates. Recent Infant Formula Problems The new rules come following several high-profile recalls issued in recent years involving infant formula. Abbott Laboratories recalled more than 5 million containers of Similac products in 2010, due to reports of contamination by insect parts. Concern was raised due to the likelihood of a child ingesting the small beetles and having difficulty feeding, breathing or other gastrointestinal problems. A class action lawsuit was filed alleging the company deceptively promoted the formula as safe and did not put adequate quality control measures in place to make sure the formula was free of beetles. In 2011, Mead Johnson Nutrition Co. recalled powdered versions of Enfamil products after the death of a Missouri baby was linked to contaminated infant formula. The baby was 10 days old and died from a Cronobacter sakazaki infection, a rare bacterium linked to contaminated baby formula. Wal-Mart initially pulled the formula from the shelves, prompting a larger recall by the FDA. Tags: Baby Formula, Bacterial Contamination, Enfamil, Infant Death, Infant Formula, Similac Image Credit: | Find Out If You Qualify for Infant Formula NEC Compensation More Baby Formula Lawsuit Stories Mead Johnson Must Face Enfamil NEC Lawsuit in Missouri State Court July 8, 2025 NEC Formula Lawsuit Set To Go Before Jury in Aug. 2025 June 23, 2025 Enfamil NEC Lawsuit Filed After Newborn Suffers ‘Nearly Total Bowel Necrosis’ June 17, 2025 1 Comments Stephanie August 8, 2019 Does anyone have any children that have health problems currently that could be related to the formula such as, seizures, chronic cough, infection, skin issues, viliago, autoimmune disease, irregular blood test,. My son has had all thiese issues and trying to narrow down why? Share Your CommentsFirst Name*Last NameEmail* Shared Comments*This field is hidden when viewing the formI authorize the above comments be posted on this page Yes No Post Comment I authorize the above comments be posted on this page Weekly Digest Opt-In Yes, send me a weekly email with the latest lawsuits, recalls and warnings. Want your comments reviewed by a lawyer?To have an attorney review your comments and contact you about a potential case, provide your contact information below. This will not be published.Contact Phone #Alt Phone #Private CommentsNOTE: Providing information for review by an attorney does not form an attorney-client relationship.CAPTCHAGA SourceGA CampaignGA MediumGA ContentGA TermPhoneThis field is for validation purposes and should be left unchanged. Δ MORE TOP STORIES Oxbryta Settlement Discussions in Class Action Lawsuits Set for Sept. 2025 (Posted: yesterday) A mediator has been appointed to oversee settlement discussions between parties involved in an Oxbryta class action lawsuit, which claims the recalled drug endangered sickle cell disease patients. MORE ABOUT: OXBRYTA LAWSUITWrongful Death Lawsuit Links Oxbryta Side Effects to Deadly Vaso-Occlusive Crises (06/05/2025)Oxbryta Recall Lawsuit Alleges Sickle Cell Drug Increased Frequency of Dangerous VOCs (05/23/2025)First Oxbryta Lawsuit Set for Trial in August 2027, Over Recalled Sickle Cell Drug Risks (05/09/2025) Lawsuit Indicates Biozorb Side Effects Left Woman With Chronic Pain, Disfiguring Injuries (Posted: 2 days ago) A BioZorb side effects lawsuit indicates that a woman is suffering chronic pain and soreness after the tissue marker implant failed to absorb into her body as advertised. MORE ABOUT: BIOZORB LAWSUITBioZorb Implant Removal Surgery: What Women Need To Know When the Device Fails To Dissolve (06/30/2025)Lawsuit Claims Biozorb Implant Penetrated Skin, Causing Massive Infection (06/04/2025)Breast Cancer Survivors File BioZorb Tissue Marker Lawsuit After Implant Fails (05/20/2025) Second Wave of Valsartan Cancer Lawsuits To Be Ready for Bellwether Trials by January 2026 (Posted: 2 days ago) A new schedule for a second wave of Valsartan cancer lawsuit bellwether trials hopes to have a case ready to go before a jury by January 2026. MORE ABOUT: VALSARTAN LAWSUITCourt Outlines Valsartan Lawsuits Trial Schedule for “Wave 2” Bellwether Cases (05/28/2025)Order Requires Valsartan Recall Lawsuits To Provide Product Identification for Specific Generic Drug Makers Named (03/27/2025)Deadlines Leading to First Valsartan Bellwether Trial on Sept. 8, 2025 Outlined by Special Master (03/04/2025)
Oxbryta Settlement Discussions in Class Action Lawsuits Set for Sept. 2025 (Posted: yesterday) A mediator has been appointed to oversee settlement discussions between parties involved in an Oxbryta class action lawsuit, which claims the recalled drug endangered sickle cell disease patients. MORE ABOUT: OXBRYTA LAWSUITWrongful Death Lawsuit Links Oxbryta Side Effects to Deadly Vaso-Occlusive Crises (06/05/2025)Oxbryta Recall Lawsuit Alleges Sickle Cell Drug Increased Frequency of Dangerous VOCs (05/23/2025)First Oxbryta Lawsuit Set for Trial in August 2027, Over Recalled Sickle Cell Drug Risks (05/09/2025)
Lawsuit Indicates Biozorb Side Effects Left Woman With Chronic Pain, Disfiguring Injuries (Posted: 2 days ago) A BioZorb side effects lawsuit indicates that a woman is suffering chronic pain and soreness after the tissue marker implant failed to absorb into her body as advertised. MORE ABOUT: BIOZORB LAWSUITBioZorb Implant Removal Surgery: What Women Need To Know When the Device Fails To Dissolve (06/30/2025)Lawsuit Claims Biozorb Implant Penetrated Skin, Causing Massive Infection (06/04/2025)Breast Cancer Survivors File BioZorb Tissue Marker Lawsuit After Implant Fails (05/20/2025)
Second Wave of Valsartan Cancer Lawsuits To Be Ready for Bellwether Trials by January 2026 (Posted: 2 days ago) A new schedule for a second wave of Valsartan cancer lawsuit bellwether trials hopes to have a case ready to go before a jury by January 2026. MORE ABOUT: VALSARTAN LAWSUITCourt Outlines Valsartan Lawsuits Trial Schedule for “Wave 2” Bellwether Cases (05/28/2025)Order Requires Valsartan Recall Lawsuits To Provide Product Identification for Specific Generic Drug Makers Named (03/27/2025)Deadlines Leading to First Valsartan Bellwether Trial on Sept. 8, 2025 Outlined by Special Master (03/04/2025)